Global Veterinary Drug Premix Market Growth 2026-2032

May 2026 | 141 pages | ID: G8FE3600BA9EEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Veterinary Drug Premix market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Veterinary medicine premix is a solid or semi solid preparation made by mixing the active ingredients of veterinary medicine with suitable excipients in a certain proportion. It is a convenient form of veterinary medicine for use and management, commonly used in livestock and poultry farming.

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from ?2.6bn in 2015 to ?4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ?67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 146%.

LP Information, Inc. (LPI) ' newest research report, the “Veterinary Drug Premix Industry Forecast” looks at past sales and reviews total world Veterinary Drug Premix sales in 2025, providing a comprehensive analysis by region and market sector of projected Veterinary Drug Premix sales for 2026 through 2032. With Veterinary Drug Premix sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Drug Premix industry.

This Insight Report provides a comprehensive analysis of the global Veterinary Drug Premix landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Drug Premix portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Drug Premix market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Drug Premix and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Drug Premix.

This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Drug Premix market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Powder
  • Particles
Segmentation by Application:
  • Plant Breeding
  • Self-Employed Person
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Bayer AG
  • Elanco
  • Zhejiang Esigma Biotechnology
  • Shandong Shengli Bioengineering
  • Jinhe Biotechnology
  • Shandong Luxi Animal Medicine Share
  • Zhengbang Group
  • Jiangsu Xinyu Pharmaceutical
  • Zhejiang Dayang Biotech Group
  • Zhengzhou Nongda Veterinary Medicine
  • China Tai Conti
  • Zhejiang Oulun Coating Technology
  • Pfizer Inc
  • Shandong Lukang Pharmaceutical
  • Zhejiang Kangmu Animal Health
  • Xinyu Pharmaceutical
  • INNER MONGOLIA Biok BIOLOGY
Key Questions Addressed in this Report
What is the 10-year outlook for the global Veterinary Drug Premix market?
What factors are driving Veterinary Drug Premix market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Drug Premix market opportunities vary by end market size?
How does Veterinary Drug Premix break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Veterinary Drug Premix Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Veterinary Drug Premix by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Veterinary Drug Premix by Country/Region, 2021, 2025 & 2032
2.2 Veterinary Drug Premix Segment by Type
  2.2.1 Powder
  2.2.2 Particles
  2.2.3 Veterinary Drug Premix Sales by Type
    2.2.3.1 Global Veterinary Drug Premix Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Veterinary Drug Premix Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Veterinary Drug Premix Sale Price by Type (2021-2026)
2.3 Veterinary Drug Premix Segment by Application
  2.3.1 Plant Breeding
  2.3.2 Self-Employed Person
  2.3.3 Veterinary Drug Premix Sales by Application
    2.3.3.1 Global Veterinary Drug Premix Sale Market Share by Application (2021-2026)
    2.3.3.2 Global Veterinary Drug Premix Revenue and Market Share by Application (2021-2026)
    2.3.3.3 Global Veterinary Drug Premix Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Veterinary Drug Premix Breakdown Data by Company
  3.1.1 Global Veterinary Drug Premix Annual Sales by Company (2021-2026)
  3.1.2 Global Veterinary Drug Premix Sales Market Share by Company (2021-2026)
3.2 Global Veterinary Drug Premix Annual Revenue by Company (2021-2026)
  3.2.1 Global Veterinary Drug Premix Revenue by Company (2021-2026)
  3.2.2 Global Veterinary Drug Premix Revenue Market Share by Company (2021-2026)
3.3 Global Veterinary Drug Premix Sale Price by Company
3.4 Key Manufacturers Veterinary Drug Premix Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Veterinary Drug Premix Product Location Distribution
  3.4.2 Players Veterinary Drug Premix Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR VETERINARY DRUG PREMIX BY GEOGRAPHIC REGION

4.1 World Historic Veterinary Drug Premix Market Size by Geographic Region (2021-2026)
  4.1.1 Global Veterinary Drug Premix Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Veterinary Drug Premix Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Veterinary Drug Premix Market Size by Country/Region (2021-2026)
  4.2.1 Global Veterinary Drug Premix Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Veterinary Drug Premix Annual Revenue by Country/Region (2021-2026)
4.3 Americas Veterinary Drug Premix Sales Growth
4.4 APAC Veterinary Drug Premix Sales Growth
4.5 Europe Veterinary Drug Premix Sales Growth
4.6 Middle East & Africa Veterinary Drug Premix Sales Growth

5 AMERICAS

5.1 Americas Veterinary Drug Premix Sales by Country
  5.1.1 Americas Veterinary Drug Premix Sales by Country (2021-2026)
  5.1.2 Americas Veterinary Drug Premix Revenue by Country (2021-2026)
5.2 Americas Veterinary Drug Premix Sales by Type (2021-2026)
5.3 Americas Veterinary Drug Premix Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Veterinary Drug Premix Sales by Region
  6.1.1 APAC Veterinary Drug Premix Sales by Region (2021-2026)
  6.1.2 APAC Veterinary Drug Premix Revenue by Region (2021-2026)
6.2 APAC Veterinary Drug Premix Sales by Type (2021-2026)
6.3 APAC Veterinary Drug Premix Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Veterinary Drug Premix by Country
  7.1.1 Europe Veterinary Drug Premix Sales by Country (2021-2026)
  7.1.2 Europe Veterinary Drug Premix Revenue by Country (2021-2026)
7.2 Europe Veterinary Drug Premix Sales by Type (2021-2026)
7.3 Europe Veterinary Drug Premix Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Veterinary Drug Premix by Country
  8.1.1 Middle East & Africa Veterinary Drug Premix Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Veterinary Drug Premix Revenue by Country (2021-2026)
8.2 Middle East & Africa Veterinary Drug Premix Sales by Type (2021-2026)
8.3 Middle East & Africa Veterinary Drug Premix Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Drug Premix
10.3 Manufacturing Process Analysis of Veterinary Drug Premix
10.4 Industry Chain Structure of Veterinary Drug Premix

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Veterinary Drug Premix Distributors
11.3 Veterinary Drug Premix Customer

12 WORLD FORECAST REVIEW FOR VETERINARY DRUG PREMIX BY GEOGRAPHIC REGION

12.1 Global Veterinary Drug Premix Market Size Forecast by Region
  12.1.1 Global Veterinary Drug Premix Forecast by Region (2027-2032)
  12.1.2 Global Veterinary Drug Premix Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Veterinary Drug Premix Forecast by Type (2027-2032)
12.7 Global Veterinary Drug Premix Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Bayer AG
  13.1.1 Bayer AG Company Information
  13.1.2 Bayer AG Veterinary Drug Premix Product Portfolios and Specifications
  13.1.3 Bayer AG Veterinary Drug Premix Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Bayer AG Main Business Overview
  13.1.5 Bayer AG Latest Developments
13.2 Elanco
  13.2.1 Elanco Company Information
  13.2.2 Elanco Veterinary Drug Premix Product Portfolios and Specifications
  13.2.3 Elanco Veterinary Drug Premix Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Elanco Main Business Overview
  13.2.5 Elanco Latest Developments
13.3 Zhejiang Esigma Biotechnology
  13.3.1 Zhejiang Esigma Biotechnology Company Information
  13.3.2 Zhejiang Esigma Biotechnology Veterinary Drug Premix Product Portfolios and Specifications
  13.3.3 Zhejiang Esigma Biotechnology Veterinary Drug Premix Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Zhejiang Esigma Biotechnology Main Business Overview
  13.3.5 Zhejiang Esigma Biotechnology Latest Developments
13.4 Shandong Shengli Bioengineering
  13.4.1 Shandong Shengli Bioengineering Company Information
  13.4.2 Shandong Shengli Bioengineering Veterinary Drug Premix Product Portfolios and Specifications
  13.4.3 Shandong Shengli Bioengineering Veterinary Drug Premix Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Shandong Shengli Bioengineering Main Business Overview
  13.4.5 Shandong Shengli Bioengineering Latest Developments
13.5 Jinhe Biotechnology
  13.5.1 Jinhe Biotechnology Company Information
  13.5.2 Jinhe Biotechnology Veterinary Drug Premix Product Portfolios and Specifications
  13.5.3 Jinhe Biotechnology Veterinary Drug Premix Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Jinhe Biotechnology Main Business Overview
  13.5.5 Jinhe Biotechnology Latest Developments
13.6 Shandong Luxi Animal Medicine Share
  13.6.1 Shandong Luxi Animal Medicine Share Company Information
  13.6.2 Shandong Luxi Animal Medicine Share Veterinary Drug Premix Product Portfolios and Specifications
  13.6.3 Shandong Luxi Animal Medicine Share Veterinary Drug Premix Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Shandong Luxi Animal Medicine Share Main Business Overview
  13.6.5 Shandong Luxi Animal Medicine Share Latest Developments
13.7 Zhengbang Group
  13.7.1 Zhengbang Group Company Information
  13.7.2 Zhengbang Group Veterinary Drug Premix Product Portfolios and Specifications
  13.7.3 Zhengbang Group Veterinary Drug Premix Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Zhengbang Group Main Business Overview
  13.7.5 Zhengbang Group Latest Developments
13.8 Jiangsu Xinyu Pharmaceutical
  13.8.1 Jiangsu Xinyu Pharmaceutical Company Information
  13.8.2 Jiangsu Xinyu Pharmaceutical Veterinary Drug Premix Product Portfolios and Specifications
  13.8.3 Jiangsu Xinyu Pharmaceutical Veterinary Drug Premix Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Jiangsu Xinyu Pharmaceutical Main Business Overview
  13.8.5 Jiangsu Xinyu Pharmaceutical Latest Developments
13.9 Zhejiang Dayang Biotech Group
  13.9.1 Zhejiang Dayang Biotech Group Company Information
  13.9.2 Zhejiang Dayang Biotech Group Veterinary Drug Premix Product Portfolios and Specifications
  13.9.3 Zhejiang Dayang Biotech Group Veterinary Drug Premix Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Zhejiang Dayang Biotech Group Main Business Overview
  13.9.5 Zhejiang Dayang Biotech Group Latest Developments
13.10 Zhengzhou Nongda Veterinary Medicine
  13.10.1 Zhengzhou Nongda Veterinary Medicine Company Information
  13.10.2 Zhengzhou Nongda Veterinary Medicine Veterinary Drug Premix Product Portfolios and Specifications
  13.10.3 Zhengzhou Nongda Veterinary Medicine Veterinary Drug Premix Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Zhengzhou Nongda Veterinary Medicine Main Business Overview
  13.10.5 Zhengzhou Nongda Veterinary Medicine Latest Developments
13.11 China Tai Conti
  13.11.1 China Tai Conti Company Information
  13.11.2 China Tai Conti Veterinary Drug Premix Product Portfolios and Specifications
  13.11.3 China Tai Conti Veterinary Drug Premix Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 China Tai Conti Main Business Overview
  13.11.5 China Tai Conti Latest Developments
13.12 Zhejiang Oulun Coating Technology
  13.12.1 Zhejiang Oulun Coating Technology Company Information
  13.12.2 Zhejiang Oulun Coating Technology Veterinary Drug Premix Product Portfolios and Specifications
  13.12.3 Zhejiang Oulun Coating Technology Veterinary Drug Premix Sales, Revenue, Price and Gross Margin (2021-2026)
  13.12.4 Zhejiang Oulun Coating Technology Main Business Overview
  13.12.5 Zhejiang Oulun Coating Technology Latest Developments
13.13 Pfizer Inc
  13.13.1 Pfizer Inc Company Information
  13.13.2 Pfizer Inc Veterinary Drug Premix Product Portfolios and Specifications
  13.13.3 Pfizer Inc Veterinary Drug Premix Sales, Revenue, Price and Gross Margin (2021-2026)
  13.13.4 Pfizer Inc Main Business Overview
  13.13.5 Pfizer Inc Latest Developments
13.14 Shandong Lukang Pharmaceutical
  13.14.1 Shandong Lukang Pharmaceutical Company Information
  13.14.2 Shandong Lukang Pharmaceutical Veterinary Drug Premix Product Portfolios and Specifications
  13.14.3 Shandong Lukang Pharmaceutical Veterinary Drug Premix Sales, Revenue, Price and Gross Margin (2021-2026)
  13.14.4 Shandong Lukang Pharmaceutical Main Business Overview
  13.14.5 Shandong Lukang Pharmaceutical Latest Developments
13.15 Zhejiang Kangmu Animal Health
  13.15.1 Zhejiang Kangmu Animal Health Company Information
  13.15.2 Zhejiang Kangmu Animal Health Veterinary Drug Premix Product Portfolios and Specifications
  13.15.3 Zhejiang Kangmu Animal Health Veterinary Drug Premix Sales, Revenue, Price and Gross Margin (2021-2026)
  13.15.4 Zhejiang Kangmu Animal Health Main Business Overview
  13.15.5 Zhejiang Kangmu Animal Health Latest Developments
13.16 Xinyu Pharmaceutical
  13.16.1 Xinyu Pharmaceutical Company Information
  13.16.2 Xinyu Pharmaceutical Veterinary Drug Premix Product Portfolios and Specifications
  13.16.3 Xinyu Pharmaceutical Veterinary Drug Premix Sales, Revenue, Price and Gross Margin (2021-2026)
  13.16.4 Xinyu Pharmaceutical Main Business Overview
  13.16.5 Xinyu Pharmaceutical Latest Developments
13.17 INNER MONGOLIA Biok BIOLOGY
  13.17.1 INNER MONGOLIA Biok BIOLOGY Company Information
  13.17.2 INNER MONGOLIA Biok BIOLOGY Veterinary Drug Premix Product Portfolios and Specifications
  13.17.3 INNER MONGOLIA Biok BIOLOGY Veterinary Drug Premix Sales, Revenue, Price and Gross Margin (2021-2026)
  13.17.4 INNER MONGOLIA Biok BIOLOGY Main Business Overview
  13.17.5 INNER MONGOLIA Biok BIOLOGY Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. Veterinary Drug Premix Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Veterinary Drug Premix Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Powder
Table 4. Major Players of Particles
Table 5. Global Veterinary Drug Premix Sales by Type (2021-2026) & (Tons)
Table 6. Global Veterinary Drug Premix Sales Market Share by Type (2021-2026)
Table 7. Global Veterinary Drug Premix Revenue by Type (2021-2026) & ($ million)
Table 8. Global Veterinary Drug Premix Revenue Market Share by Type (2021-2026)
Table 9. Global Veterinary Drug Premix Sale Price by Type (2021-2026) & (US$/Ton)
Table 10. Global Veterinary Drug Premix Sale by Application (2021-2026) & (Tons)
Table 11. Global Veterinary Drug Premix Sale Market Share by Application (2021-2026)
Table 12. Global Veterinary Drug Premix Revenue by Application (2021-2026) & ($ million)
Table 13. Global Veterinary Drug Premix Revenue Market Share by Application (2021-2026)
Table 14. Global Veterinary Drug Premix Sale Price by Application (2021-2026) & (US$/Ton)
Table 15. Global Veterinary Drug Premix Sales by Company (2021-2026) & (Tons)
Table 16. Global Veterinary Drug Premix Sales Market Share by Company (2021-2026)
Table 17. Global Veterinary Drug Premix Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Veterinary Drug Premix Revenue Market Share by Company (2021-2026)
Table 19. Global Veterinary Drug Premix Sale Price by Company (2021-2026) & (US$/Ton)
Table 20. Key Manufacturers Veterinary Drug Premix Producing Area Distribution and Sales Area
Table 21. Players Veterinary Drug Premix Products Offered
Table 22. Veterinary Drug Premix Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Veterinary Drug Premix Sales by Geographic Region (2021-2026) & (Tons)
Table 26. Global Veterinary Drug Premix Sales Market Share Geographic Region (2021-2026)
Table 27. Global Veterinary Drug Premix Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Veterinary Drug Premix Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Veterinary Drug Premix Sales by Country/Region (2021-2026) & (Tons)
Table 30. Global Veterinary Drug Premix Sales Market Share by Country/Region (2021-2026)
Table 31. Global Veterinary Drug Premix Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Veterinary Drug Premix Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Veterinary Drug Premix Sales by Country (2021-2026) & (Tons)
Table 34. Americas Veterinary Drug Premix Sales Market Share by Country (2021-2026)
Table 35. Americas Veterinary Drug Premix Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Veterinary Drug Premix Sales by Type (2021-2026) & (Tons)
Table 37. Americas Veterinary Drug Premix Sales by Application (2021-2026) & (Tons)
Table 38. APAC Veterinary Drug Premix Sales by Region (2021-2026) & (Tons)
Table 39. APAC Veterinary Drug Premix Sales Market Share by Region (2021-2026)
Table 40. APAC Veterinary Drug Premix Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Veterinary Drug Premix Sales by Type (2021-2026) & (Tons)
Table 42. APAC Veterinary Drug Premix Sales by Application (2021-2026) & (Tons)
Table 43. Europe Veterinary Drug Premix Sales by Country (2021-2026) & (Tons)
Table 44. Europe Veterinary Drug Premix Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Veterinary Drug Premix Sales by Type (2021-2026) & (Tons)
Table 46. Europe Veterinary Drug Premix Sales by Application (2021-2026) & (Tons)
Table 47. Middle East & Africa Veterinary Drug Premix Sales by Country (2021-2026) & (Tons)
Table 48. Middle East & Africa Veterinary Drug Premix Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Veterinary Drug Premix Sales by Type (2021-2026) & (Tons)
Table 50. Middle East & Africa Veterinary Drug Premix Sales by Application (2021-2026) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of Veterinary Drug Premix
Table 52. Key Market Challenges & Risks of Veterinary Drug Premix
Table 53. Key Industry Trends of Veterinary Drug Premix
Table 54. Veterinary Drug Premix Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Veterinary Drug Premix Distributors List
Table 57. Veterinary Drug Premix Customer List
Table 58. Global Veterinary Drug Premix Sales Forecast by Region (2027-2032) & (Tons)
Table 59. Global Veterinary Drug Premix Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Veterinary Drug Premix Sales Forecast by Country (2027-2032) & (Tons)
Table 61. Americas Veterinary Drug Premix Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Veterinary Drug Premix Sales Forecast by Region (2027-2032) & (Tons)
Table 63. APAC Veterinary Drug Premix Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Veterinary Drug Premix Sales Forecast by Country (2027-2032) & (Tons)
Table 65. Europe Veterinary Drug Premix Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Veterinary Drug Premix Sales Forecast by Country (2027-2032) & (Tons)
Table 67. Middle East & Africa Veterinary Drug Premix Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Veterinary Drug Premix Sales Forecast by Type (2027-2032) & (Tons)
Table 69. Global Veterinary Drug Premix Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Veterinary Drug Premix Sales Forecast by Application (2027-2032) & (Tons)
Table 71. Global Veterinary Drug Premix Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Bayer AG Basic Information, Veterinary Drug Premix Manufacturing Base, Sales Area and Its Competitors
Table 73. Bayer AG Veterinary Drug Premix Product Portfolios and Specifications
Table 74. Bayer AG Veterinary Drug Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 75. Bayer AG Main Business
Table 76. Bayer AG Latest Developments
Table 77. Elanco Basic Information, Veterinary Drug Premix Manufacturing Base, Sales Area and Its Competitors
Table 78. Elanco Veterinary Drug Premix Product Portfolios and Specifications
Table 79. Elanco Veterinary Drug Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 80. Elanco Main Business
Table 81. Elanco Latest Developments
Table 82. Zhejiang Esigma Biotechnology Basic Information, Veterinary Drug Premix Manufacturing Base, Sales Area and Its Competitors
Table 83. Zhejiang Esigma Biotechnology Veterinary Drug Premix Product Portfolios and Specifications
Table 84. Zhejiang Esigma Biotechnology Veterinary Drug Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 85. Zhejiang Esigma Biotechnology Main Business
Table 86. Zhejiang Esigma Biotechnology Latest Developments
Table 87. Shandong Shengli Bioengineering Basic Information, Veterinary Drug Premix Manufacturing Base, Sales Area and Its Competitors
Table 88. Shandong Shengli Bioengineering Veterinary Drug Premix Product Portfolios and Specifications
Table 89. Shandong Shengli Bioengineering Veterinary Drug Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 90. Shandong Shengli Bioengineering Main Business
Table 91. Shandong Shengli Bioengineering Latest Developments
Table 92. Jinhe Biotechnology Basic Information, Veterinary Drug Premix Manufacturing Base, Sales Area and Its Competitors
Table 93. Jinhe Biotechnology Veterinary Drug Premix Product Portfolios and Specifications
Table 94. Jinhe Biotechnology Veterinary Drug Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 95. Jinhe Biotechnology Main Business
Table 96. Jinhe Biotechnology Latest Developments
Table 97. Shandong Luxi Animal Medicine Share Basic Information, Veterinary Drug Premix Manufacturing Base, Sales Area and Its Competitors
Table 98. Shandong Luxi Animal Medicine Share Veterinary Drug Premix Product Portfolios and Specifications
Table 99. Shandong Luxi Animal Medicine Share Veterinary Drug Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 100. Shandong Luxi Animal Medicine Share Main Business
Table 101. Shandong Luxi Animal Medicine Share Latest Developments
Table 102. Zhengbang Group Basic Information, Veterinary Drug Premix Manufacturing Base, Sales Area and Its Competitors
Table 103. Zhengbang Group Veterinary Drug Premix Product Portfolios and Specifications
Table 104. Zhengbang Group Veterinary Drug Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 105. Zhengbang Group Main Business
Table 106. Zhengbang Group Latest Developments
Table 107. Jiangsu Xinyu Pharmaceutical Basic Information, Veterinary Drug Premix Manufacturing Base, Sales Area and Its Competitors
Table 108. Jiangsu Xinyu Pharmaceutical Veterinary Drug Premix Product Portfolios and Specifications
Table 109. Jiangsu Xinyu Pharmaceutical Veterinary Drug Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 110. Jiangsu Xinyu Pharmaceutical Main Business
Table 111. Jiangsu Xinyu Pharmaceutical Latest Developments
Table 112. Zhejiang Dayang Biotech Group Basic Information, Veterinary Drug Premix Manufacturing Base, Sales Area and Its Competitors
Table 113. Zhejiang Dayang Biotech Group Veterinary Drug Premix Product Portfolios and Specifications
Table 114. Zhejiang Dayang Biotech Group Veterinary Drug Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 115. Zhejiang Dayang Biotech Group Main Business
Table 116. Zhejiang Dayang Biotech Group Latest Developments
Table 117. Zhengzhou Nongda Veterinary Medicine Basic Information, Veterinary Drug Premix Manufacturing Base, Sales Area and Its Competitors
Table 118. Zhengzhou Nongda Veterinary Medicine Veterinary Drug Premix Product Portfolios and Specifications
Table 119. Zhengzhou Nongda Veterinary Medicine Veterinary Drug Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 120. Zhengzhou Nongda Veterinary Medicine Main Business
Table 121. Zhengzhou Nongda Veterinary Medicine Latest Developments
Table 122. China Tai Conti Basic Information, Veterinary Drug Premix Manufacturing Base, Sales Area and Its Competitors
Table 123. China Tai Conti Veterinary Drug Premix Product Portfolios and Specifications
Table 124. China Tai Conti Veterinary Drug Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 125. China Tai Conti Main Business
Table 126. China Tai Conti Latest Developments
Table 127. Zhejiang Oulun Coating Technology Basic Information, Veterinary Drug Premix Manufacturing Base, Sales Area and Its Competitors
Table 128. Zhejiang Oulun Coating Technology Veterinary Drug Premix Product Portfolios and Specifications
Table 129. Zhejiang Oulun Coating Technology Veterinary Drug Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 130. Zhejiang Oulun Coating Technology Main Business
Table 131. Zhejiang Oulun Coating Technology Latest Developments
Table 132. Pfizer Inc Basic Information, Veterinary Drug Premix Manufacturing Base, Sales Area and Its Competitors
Table 133. Pfizer Inc Veterinary Drug Premix Product Portfolios and Specifications
Table 134. Pfizer Inc Veterinary Drug Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 135. Pfizer Inc Main Business
Table 136. Pfizer Inc Latest Developments
Table 137. Shandong Lukang Pharmaceutical Basic Information, Veterinary Drug Premix Manufacturing Base, Sales Area and Its Competitors
Table 138. Shandong Lukang Pharmaceutical Veterinary Drug Premix Product Portfolios and Specifications
Table 139. Shandong Lukang Pharmaceutical Veterinary Drug Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 140. Shandong Lukang Pharmaceutical Main Business
Table 141. Shandong Lukang Pharmaceutical Latest Developments
Table 142. Zhejiang Kangmu Animal Health Basic Information, Veterinary Drug Premix Manufacturing Base, Sales Area and Its Competitors
Table 143. Zhejiang Kangmu Animal Health Veterinary Drug Premix Product Portfolios and Specifications
Table 144. Zhejiang Kangmu Animal Health Veterinary Drug Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 145. Zhejiang Kangmu Animal Health Main Business
Table 146. Zhejiang Kangmu Animal Health Latest Developments
Table 147. Xinyu Pharmaceutical Basic Information, Veterinary Drug Premix Manufacturing Base, Sales Area and Its Competitors
Table 148. Xinyu Pharmaceutical Veterinary Drug Premix Product Portfolios and Specifications
Table 149. Xinyu Pharmaceutical Veterinary Drug Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 150. Xinyu Pharmaceutical Main Business
Table 151. Xinyu Pharmaceutical Latest Developments
Table 152. INNER MONGOLIA Biok BIOLOGY Basic Information, Veterinary Drug Premix Manufacturing Base, Sales Area and Its Competitors
Table 153. INNER MONGOLIA Biok BIOLOGY Veterinary Drug Premix Product Portfolios and Specifications
Table 154. INNER MONGOLIA Biok BIOLOGY Veterinary Drug Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 155. INNER MONGOLIA Biok BIOLOGY Main Business
Table 156. INNER MONGOLIA Biok BIOLOGY Latest Developments

LIST OF FIGURES

Figure 1. Picture of Veterinary Drug Premix
Figure 2. Veterinary Drug Premix Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Drug Premix Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Veterinary Drug Premix Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Veterinary Drug Premix Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Veterinary Drug Premix Sales Market Share by Country/Region (2025)
Figure 10. Veterinary Drug Premix Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Powder
Figure 12. Product Picture of Particles
Figure 13. Global Veterinary Drug Premix Sales Market Share by Type in 2026
Figure 14. Global Veterinary Drug Premix Revenue Market Share by Type (2021-2026)
Figure 15. Veterinary Drug Premix Consumed in Plant Breeding
Figure 16. Global Veterinary Drug Premix Market: Plant Breeding (2021-2026) & (Tons)
Figure 17. Veterinary Drug Premix Consumed in Self-Employed Person
Figure 18. Global Veterinary Drug Premix Market: Self-Employed Person (2021-2026) & (Tons)
Figure 19. Global Veterinary Drug Premix Sale Market Share by Application (2025)
Figure 20. Global Veterinary Drug Premix Revenue Market Share by Application in 2026
Figure 21. Veterinary Drug Premix Sales by Company in 2026 (Tons)
Figure 22. Global Veterinary Drug Premix Sales Market Share by Company in 2026
Figure 23. Veterinary Drug Premix Revenue by Company in 2026 ($ millions)
Figure 24. Global Veterinary Drug Premix Revenue Market Share by Company in 2026
Figure 25. Global Veterinary Drug Premix Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Veterinary Drug Premix Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Veterinary Drug Premix Sales 2021-2026 (Tons)
Figure 28. Americas Veterinary Drug Premix Revenue 2021-2026 ($ millions)
Figure 29. APAC Veterinary Drug Premix Sales 2021-2026 (Tons)
Figure 30. APAC Veterinary Drug Premix Revenue 2021-2026 ($ millions)
Figure 31. Europe Veterinary Drug Premix Sales 2021-2026 (Tons)
Figure 32. Europe Veterinary Drug Premix Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Veterinary Drug Premix Sales 2021-2026 (Tons)
Figure 34. Middle East & Africa Veterinary Drug Premix Revenue 2021-2026 ($ millions)
Figure 35. Americas Veterinary Drug Premix Sales Market Share by Country in 2026
Figure 36. Americas Veterinary Drug Premix Revenue Market Share by Country (2021-2026)
Figure 37. Americas Veterinary Drug Premix Sales Market Share by Type (2021-2026)
Figure 38. Americas Veterinary Drug Premix Sales Market Share by Application (2021-2026)
Figure 39. United States Veterinary Drug Premix Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Veterinary Drug Premix Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Veterinary Drug Premix Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Veterinary Drug Premix Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Veterinary Drug Premix Sales Market Share by Region in 2026
Figure 44. APAC Veterinary Drug Premix Revenue Market Share by Region (2021-2026)
Figure 45. APAC Veterinary Drug Premix Sales Market Share by Type (2021-2026)
Figure 46. APAC Veterinary Drug Premix Sales Market Share by Application (2021-2026)
Figure 47. China Veterinary Drug Premix Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Veterinary Drug Premix Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Veterinary Drug Premix Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Veterinary Drug Premix Revenue Growth 2021-2026 ($ millions)
Figure 51. India Veterinary Drug Premix Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Veterinary Drug Premix Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Veterinary Drug Premix Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Veterinary Drug Premix Sales Market Share by Country in 2026
Figure 55. Europe Veterinary Drug Premix Revenue Market Share by Country (2021-2026)
Figure 56. Europe Veterinary Drug Premix Sales Market Share by Type (2021-2026)
Figure 57. Europe Veterinary Drug Premix Sales Market Share by Application (2021-2026)
Figure 58. Germany Veterinary Drug Premix Revenue Growth 2021-2026 ($ millions)
Figure 59. France Veterinary Drug Premix Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Veterinary Drug Premix Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Veterinary Drug Premix Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Veterinary Drug Premix Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Veterinary Drug Premix Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Veterinary Drug Premix Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Veterinary Drug Premix Sales Market Share by Application (2021-2026)
Figure 66. Egypt Veterinary Drug Premix Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Veterinary Drug Premix Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Veterinary Drug Premix Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Veterinary Drug Premix Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Veterinary Drug Premix Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Veterinary Drug Premix in 2026
Figure 72. Manufacturing Process Analysis of Veterinary Drug Premix
Figure 73. Industry Chain Structure of Veterinary Drug Premix
Figure 74. Channels of Distribution
Figure 75. Global Veterinary Drug Premix Sales Market Forecast by Region (2027-2032)
Figure 76. Global Veterinary Drug Premix Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Veterinary Drug Premix Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Veterinary Drug Premix Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Veterinary Drug Premix Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Veterinary Drug Premix Revenue Market Share Forecast by Application (2027-2032)


More Publications